Jake Simson, Ph.D. | Non-executive Director
Jake Simson is a Principal on the investment team at RA Capital Management, where his primary responsibility is to conduct due diligence on biotechnology companies. Prior to this role, Jake was a Senior Associate on the Landscape Team within the TechAtlas division of RA Capital, where he mapped competitive landscapes in the solid tumor oncology space and performed in-depth analyses of pharma pipelines. In addition to being a board member of Xenikos, Jake also acts as an observer on the board of Arvinas.
Jake holds a BS in materials science and engineering from MIT and a Ph.D. in biomedical engineering from Johns Hopkins University. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels.